Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.955 USD | -0.72% | +40.56% | +512.93% |
04-11 | Sector Update: Health Care Stocks Decline Thursday Afternoon | MT |
04-11 | Candel Therapeutics Shares Rise After FDA Orphan Drug Designation for Potential Pancreatic Cancer Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+512.93% | 265M | |
+21.89% | 47.9B | |
+46.56% | 41.42B | |
-2.37% | 40.7B | |
-6.20% | 28.92B | |
+10.96% | 25.55B | |
-21.58% | 19.27B | |
-1.55% | 12.15B | |
+30.51% | 12.14B | |
-0.63% | 11.99B |
- Stock Market
- Equities
- CADL Stock
- News Candel Therapeutics, Inc.
- Candel Therapeutics : Credit Suisse Starts Candel Therapeutics at Outperform with $15 PT, Notes Potential for Improved Investor Sentiment, Valuation